Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
raltegravir (isentress) (1 trial)
zidovudine (retrovir) (1 trial)
Communicable Diseases (Phase 1)
HTLV-I Infections (Phase 1)
Infections (Phase 1)
Muscle Spasticity (Phase 1)
Paraparesis (Phase 1)
Paraparesis, Spastic (Phase 1)
Paraparesis, Tropical Spastic (Phase 1)
Trials (1 total)
Trial APIs (2 total)